Agios Pharmaceuticals (AGIO)

$43.33 +1.24 (2.95%)
Market Cap 2.52B
Revenue (ttm) 36.50M
Net Income (ttm) 673.73M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 1,845.84%
Debt to Equity Ratio 0.00
Volume 343,000
Avg Vol 649,282
Day's Range N/A - N/A
Shares Out 58.10M
Stochastic %K 91%
Beta 0.83
Analysts Sell
Price Target $46.67

Company Profile

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes used for the treatment of hemolytic anemias in adults with PK deficiency. The company's PYRUKYND product also used for the treatment of sickle cell disease that is in phase 3 clinical trial; for the treatment of PK deficiency in pediatr...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 649 8600
Address:
88 Sidney Street, Cambridge, United States
ImPoorAndHungry
ImPoorAndHungry Oct. 26 at 2:14 AM
$AGIO $65-$75 Dec 7th
0 · Reply
Lavishstock
Lavishstock Oct. 25 at 3:45 PM
$AGIO NICE set up! ⸻ 💡 AI Tool I Use to Track All These: Been testing Comet Browser (by Perplexity AI) — it summarizes crypto charts, news & sentiment instantly. ✅ 100% free trial ✅ No credit card needed ✅ Built-in AI assistant 👉 Try it here: https://pplx.ai/maxmasoodi63049
0 · Reply
Tumble51
Tumble51 Oct. 25 at 3:18 PM
$AGGY $AGIO you and the chartists are just without foundation ..you are that naive ...laughed at daily
1 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 25 at 3:00 PM
$AGGY $AGIO Its bull shit! And math don't lie! Week after week after accuracy list after list! 🔥 Cycle Trading Signal plugged into AI 🔥 only for people that know how to count and know how to spell bull shit!
0 · Reply
Tumble51
Tumble51 Oct. 25 at 2:56 PM
$AGGY $AGIO Bull siht
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 24 at 9:55 PM
Cycle Trading Signal plugged into AI 🔥 List 10/10 to 10/24 results $AGGY $AGIO $AGX.X $AGM $AGO
0 · Reply
ImPoorAndHungry
ImPoorAndHungry Oct. 22 at 5:40 PM
$AGIO hopefully earnings can save this
0 · Reply
ImPoorAndHungry
ImPoorAndHungry Oct. 22 at 12:50 PM
$AGIO selling at 44.25
0 · Reply
stu4
stu4 Oct. 22 at 11:14 AM
$AGIO Directions : See loser below ⬇️ Instigated Law Suit due to intregity in releases
0 · Reply
ImPoorAndHungry
ImPoorAndHungry Oct. 22 at 9:06 AM
$AGIO #jadek6 #Tumble51
0 · Reply
Latest News on AGIO
Avanzanite Bioscience's Partner Agios Announces Positive CHMP Opinion for PYRUKYND® (mitapivat) for Adults with Thalassemia

Oct 17, 2025, 8:15 AM EDT - 8 days ago

Avanzanite Bioscience's Partner Agios Announces Positive CHMP Opinion for PYRUKYND® (mitapivat) for Adults with Thalassemia

Agios' PYRUKYND® (mitapivat) Receives Positive CHMP Opinion for Adults with Thalassemia

Oct 17, 2025, 8:00 AM EDT - 8 days ago

Agios' PYRUKYND® (mitapivat) Receives Positive CHMP Opinion for Adults with Thalassemia

Agios to Host Third Quarter 2025 Financial Results Conference Call and Webcast on October 30 at 8:00 a.m. ET

Oct 16, 2025, 7:00 AM EDT - 9 days ago

Agios to Host Third Quarter 2025 Financial Results Conference Call and Webcast on October 30 at 8:00 a.m. ET

AGIO Investors Have Opportunity to Join Agios Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm

Sep 18, 2025, 5:49 AM EDT - 5 weeks ago

AGIO Investors Have Opportunity to Join Agios Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm

AGIO Investors Have Opportunity to Join Agios Pharmaceuticals, Inc. Fraud Investigation With the Schall Law Firm

Sep 15, 2025, 12:20 PM EDT - 5 weeks ago

AGIO Investors Have Opportunity to Join Agios Pharmaceuticals, Inc. Fraud Investigation With the Schall Law Firm

Agios Pharmaceuticals: Why A Delayed FDA Review Could Still Be A Positive

Sep 8, 2025, 10:32 AM EDT - 6 weeks ago

Agios Pharmaceuticals: Why A Delayed FDA Review Could Still Be A Positive

Agios Pharmaceuticals: New FDA Setback Likely Temporary As Issues Can Be Mitigated

Sep 4, 2025, 12:46 PM EDT - 7 weeks ago

Agios Pharmaceuticals: New FDA Setback Likely Temporary As Issues Can Be Mitigated

FDA Delays Decision On Agios Pharmaceuticals' Blood Disorder Drug For Expanded Use

Sep 4, 2025, 10:49 AM EDT - 7 weeks ago

FDA Delays Decision On Agios Pharmaceuticals' Blood Disorder Drug For Expanded Use

Agios Provides Update on U.S. PDUFA Goal Date for PYRUKYND® (mitapivat) in Thalassemia

Sep 4, 2025, 7:00 AM EDT - 7 weeks ago

Agios Provides Update on U.S. PDUFA Goal Date for PYRUKYND® (mitapivat) in Thalassemia

Agios' PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia

Aug 4, 2025, 4:01 PM EDT - 2 months ago

Agios' PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia

Agios Pharmaceuticals, Inc. (AGIO) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 5:02 PM EDT - 3 months ago

Agios Pharmaceuticals, Inc. (AGIO) Q2 2025 Earnings Call Transcript

Agios Reports Second Quarter 2025 Financial Results and Provides Business Update

Jul 31, 2025, 6:30 AM EDT - 3 months ago

Agios Reports Second Quarter 2025 Financial Results and Provides Business Update

Agios to Host Webcast Conference Call of Second Quarter Financial Results on July 31, 2025 at 8:00am ET

Jul 14, 2025, 7:00 AM EDT - 3 months ago

Agios to Host Webcast Conference Call of Second Quarter Financial Results on July 31, 2025 at 8:00am ET

Agios Appoints Dr. Jay Backstrom to Board of Directors

Jul 8, 2025, 7:00 AM EDT - 3 months ago

Agios Appoints Dr. Jay Backstrom to Board of Directors

Avanzanite Announces Pan-European Partnership with Agios to Launch PYRUKYND® in Rare Blood Disorders

Jun 9, 2025, 8:40 AM EDT - 4 months ago

Avanzanite Announces Pan-European Partnership with Agios to Launch PYRUKYND® in Rare Blood Disorders

Agios to Present at Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025

May 28, 2025, 7:00 AM EDT - 5 months ago

Agios to Present at Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025

Agios to Highlight Pyruvate Kinase Activation Portfolio with New Data in Rare Blood Disorders at 30th EHA Congress

May 14, 2025, 10:00 AM EDT - 5 months ago

Agios to Highlight Pyruvate Kinase Activation Portfolio with New Data in Rare Blood Disorders at 30th EHA Congress

Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025

May 9, 2025, 7:00 AM EDT - 6 months ago

Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025

Agios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025

May 2, 2025, 7:00 AM EDT - 6 months ago

Agios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025

Agios Pharmaceuticals, Inc. (AGIO) Q1 2025 Earnings Call Transcript

May 1, 2025, 12:06 PM EDT - 6 months ago

Agios Pharmaceuticals, Inc. (AGIO) Q1 2025 Earnings Call Transcript

Agios Reports First Quarter 2025 Financial Results and Recent Business Highlights

May 1, 2025, 6:30 AM EDT - 6 months ago

Agios Reports First Quarter 2025 Financial Results and Recent Business Highlights

Agios to Webcast Conference Call of First Quarter Financial Results on May 1, 2025

Apr 17, 2025, 7:00 AM EDT - 6 months ago

Agios to Webcast Conference Call of First Quarter Financial Results on May 1, 2025

Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy Officer

Mar 5, 2025, 5:52 PM EST - 8 months ago

Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy Officer

Agios to Present at Upcoming Investor Conferences

Mar 4, 2025, 7:00 AM EST - 8 months ago

Agios to Present at Upcoming Investor Conferences

Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025

Feb 20, 2025, 7:00 AM EST - 8 months ago

Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025

Agios Pharmaceuticals, Inc. (AGIO) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 1:32 PM EST - 9 months ago

Agios Pharmaceuticals, Inc. (AGIO) Q4 2024 Earnings Call Transcript

Agios Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

Feb 13, 2025, 6:31 AM EST - 9 months ago

Agios Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

Agios' Phase 3 ACTIVATE-Kids Study of Mitapivat in Children with Pyruvate Kinase (PK) Deficiency Not Regularly Transfused Met Primary Endpoint

Feb 13, 2025, 6:30 AM EST - 9 months ago

Agios' Phase 3 ACTIVATE-Kids Study of Mitapivat in Children with Pyruvate Kinase (PK) Deficiency Not Regularly Transfused Met Primary Endpoint

Agios to Webcast Conference Call of Fourth Quarter and Full Year 2024 Financial Results on February 13, 2025

Feb 6, 2025, 7:00 AM EST - 9 months ago

Agios to Webcast Conference Call of Fourth Quarter and Full Year 2024 Financial Results on February 13, 2025

Cardurion Pharmaceuticals Appoints Charlotte Newman as Chief Business Officer

Jan 8, 2025, 8:00 AM EST - 10 months ago

Cardurion Pharmaceuticals Appoints Charlotte Newman as Chief Business Officer

BIIB

Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025

Jan 3, 2025, 7:00 AM EST - 10 months ago

Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025

European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios' Mitapivat in Sickle Cell Disease

Dec 18, 2024, 7:00 AM EST - 11 months ago

European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios' Mitapivat in Sickle Cell Disease

Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivat at ASH 2024 and Provides Regulatory Update on Mitapivat

Dec 8, 2024, 12:40 PM EST - 11 months ago

Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivat at ASH 2024 and Provides Regulatory Update on Mitapivat

Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition

Nov 5, 2024, 9:05 AM EST - 1 year ago

Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition

Agios Pharmaceuticals, Inc. (AGIO) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 2:16 PM EDT - 1 year ago

Agios Pharmaceuticals, Inc. (AGIO) Q3 2024 Earnings Call Transcript

Agios Reports Business Highlights and Third Quarter 2024 Financial Results

Oct 31, 2024, 6:30 AM EDT - 1 year ago

Agios Reports Business Highlights and Third Quarter 2024 Financial Results

Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024

Oct 17, 2024, 7:00 AM EDT - 1 year ago

Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024

Agios Announces FDA Orphan Drug Designation Granted to Tebapivat (AG-946) for Treatment of Myelodysplastic Syndromes (MDS)

Sep 11, 2024, 7:00 AM EDT - 1 year ago

Agios Announces FDA Orphan Drug Designation Granted to Tebapivat (AG-946) for Treatment of Myelodysplastic Syndromes (MDS)

Agios to Present at the 2024 Cantor Global Healthcare Conference on September 18, 2024

Sep 5, 2024, 7:00 AM EDT - 1 year ago

Agios to Present at the 2024 Cantor Global Healthcare Conference on September 18, 2024

Agios' Mitapivat: A Potential Blockbuster In Thalassemia Treatment

Aug 27, 2024, 10:18 AM EDT - 1 year ago

Agios' Mitapivat: A Potential Blockbuster In Thalassemia Treatment

Agios to Receive $1.1 Billion in Milestone Payments Following FDA Approval of Vorasidenib

Aug 6, 2024, 5:50 PM EDT - 1 year ago

Agios to Receive $1.1 Billion in Milestone Payments Following FDA Approval of Vorasidenib

Agios Pharmaceuticals' Rare Blood Disorder Drug Misses Primary Goal In Pediatric Study, Stock Slides

Aug 1, 2024, 1:42 PM EDT - 1 year ago

Agios Pharmaceuticals' Rare Blood Disorder Drug Misses Primary Goal In Pediatric Study, Stock Slides

Agios Pharmaceuticals, Inc. (AGIO) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 12:11 PM EDT - 1 year ago

Agios Pharmaceuticals, Inc. (AGIO) Q2 2024 Earnings Call Transcript

Agios Reports Business Highlights and Second Quarter 2024 Financial Results

Aug 1, 2024, 6:31 AM EDT - 1 year ago

Agios Reports Business Highlights and Second Quarter 2024 Financial Results

Agios Announces Results from Phase 3 ACTIVATE-KidsT Study of Mitapivat in Children with PK Deficiency Who Are Regularly Transfused

Aug 1, 2024, 6:30 AM EDT - 1 year ago

Agios Announces Results from Phase 3 ACTIVATE-KidsT Study of Mitapivat in Children with PK Deficiency Who Are Regularly Transfused

Agios to Webcast Conference Call of Second Quarter 2024 Financial Results on August 1, 2024

Jul 18, 2024, 7:00 AM EDT - 1 year ago

Agios to Webcast Conference Call of Second Quarter 2024 Financial Results on August 1, 2024

Agios Pharmaceuticals: Potential Acquisition Target, Upcoming FDA Approvals, Promising Pipeline

Jun 12, 2024, 7:41 AM EDT - 1 year ago

Agios Pharmaceuticals: Potential Acquisition Target, Upcoming FDA Approvals, Promising Pipeline

Agios Pharmaceuticals' blood disorder drug succeeds in late-stage study

Jun 3, 2024, 6:42 AM EDT - 1 year ago

Agios Pharmaceuticals' blood disorder drug succeeds in late-stage study

ImPoorAndHungry
ImPoorAndHungry Oct. 26 at 2:14 AM
$AGIO $65-$75 Dec 7th
0 · Reply
Lavishstock
Lavishstock Oct. 25 at 3:45 PM
$AGIO NICE set up! ⸻ 💡 AI Tool I Use to Track All These: Been testing Comet Browser (by Perplexity AI) — it summarizes crypto charts, news & sentiment instantly. ✅ 100% free trial ✅ No credit card needed ✅ Built-in AI assistant 👉 Try it here: https://pplx.ai/maxmasoodi63049
0 · Reply
Tumble51
Tumble51 Oct. 25 at 3:18 PM
$AGGY $AGIO you and the chartists are just without foundation ..you are that naive ...laughed at daily
1 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 25 at 3:00 PM
$AGGY $AGIO Its bull shit! And math don't lie! Week after week after accuracy list after list! 🔥 Cycle Trading Signal plugged into AI 🔥 only for people that know how to count and know how to spell bull shit!
0 · Reply
Tumble51
Tumble51 Oct. 25 at 2:56 PM
$AGGY $AGIO Bull siht
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 24 at 9:55 PM
Cycle Trading Signal plugged into AI 🔥 List 10/10 to 10/24 results $AGGY $AGIO $AGX.X $AGM $AGO
0 · Reply
ImPoorAndHungry
ImPoorAndHungry Oct. 22 at 5:40 PM
$AGIO hopefully earnings can save this
0 · Reply
ImPoorAndHungry
ImPoorAndHungry Oct. 22 at 12:50 PM
$AGIO selling at 44.25
0 · Reply
stu4
stu4 Oct. 22 at 11:14 AM
$AGIO Directions : See loser below ⬇️ Instigated Law Suit due to intregity in releases
0 · Reply
ImPoorAndHungry
ImPoorAndHungry Oct. 22 at 9:06 AM
$AGIO #jadek6 #Tumble51
0 · Reply
ImPoorAndHungry
ImPoorAndHungry Oct. 21 at 10:00 AM
$AGIO free shares… don’t mind if I do #GoffGang
0 · Reply
Tumble51
Tumble51 Oct. 20 at 5:29 PM
$AGIO Absolutely !!! Hey , Chief..check out this clown , off his meds
1 · Reply
Tumble51
Tumble51 Oct. 20 at 5:28 PM
$AGIO Haha Christ wasn’t a loser , he was a savior !! This clown owns , LOSER ..right Jack ?
0 · Reply
Tumble51
Tumble51 Oct. 20 at 5:25 PM
$AGIO No FOMO’s at this pos. !!! There are other places in biotech They know the mgmt team ..BLOWS
0 · Reply
Jadek6
Jadek6 Oct. 20 at 3:28 PM
$AGIO a sad sad pathetic CEO..should be nailed to a plank, not a cross. He can't even save uismown sins of “ oh did we mention that the liver could be an issue “ Such a loser
0 · Reply
Jadek6
Jadek6 Oct. 20 at 3:09 PM
$AGIO and how is Goat siht today ..let me guess market up 300 , Dow hitting new highs , and the misfits at AGIO , and the goat herder , are seeing , no volume and RED Did I get that right , hahahaha Siht never flows up hill even , Christ knew that
0 · Reply
ImPoorAndHungry
ImPoorAndHungry Oct. 20 at 12:12 PM
$AGIO
0 · Reply
Jadek6
Jadek6 Oct. 20 at 11:50 AM
$AGIO here is a bold face lie !!! he cried and cried ..bought to high ..had to wait for the misfits to say something to get it above his price ! An options clown, a lover of the Goof Goff Try another con on the other posters here
1 · Reply
stu4
stu4 Oct. 19 at 10:55 PM
$AGIO can’t get burned when there is no fire, never was, never will be here. Doing DD, eliminates , hacks , misfits, bouncing around execs for 25 years with dismal reputations. Sad, you didn’t , lol .! These clowns at AGIO were give always to intelligent people. Karp….anyone seen Karp ? Oh he is busy building value Fouse ? Busy cleaning goat stalls
0 · Reply
Dkll303
Dkll303 Oct. 18 at 1:12 PM
$AGIO Yes, lol, all listen to a poster that chooses loser senior execs at this pos , and follow the trail to the next , AQST ( notice no $) .no one else needs to read his BS or subsequent comments from truthful posters here Fouse, Goff, Jones, Milanova ..losers
0 · Reply
ImPoorAndHungry
ImPoorAndHungry Oct. 18 at 3:16 AM
$AGIO everyone go to #AQST, up 40% in 4 month and stock is currently on a pullback. PDUFA date 1/31/26
0 · Reply
Jadek6
Jadek6 Oct. 18 at 1:01 AM
$AGIO …a true loser writes rhetorical bull crap like this Been following these loser senior execs from their other failures in life Fouse at celegen Fouse at Bunge Goff ..just a middle man hack, bureaucrat Jones ..another useless cfo Biller left , he saw constant mgmt failures , went to vertex His options rewarded him HUGE ..NOT HERE and this clown @ImPoorAndHungry , was cry8ng last week to GTFO Knowing that the DD, I shared was true Burned by these a$$ holes , no , Mande money and left them,due to incompetence !!! Wake up poor and hungry, !!!!
1 · Reply